Cystic Kidney Disease: A congenital or acquired kidney disorder characterized by the presence of renal cysts.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1187 |
4. Check minimum number of eventsNone |
1187 |
5. Include endpointsNone |
1187 |
6. Filter based on genotype QC (FinnGen only) |
1187 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_URINARY_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[0-4]
- Name in latin
- Morbus cysticus renalis
Similar endpoints
↥List of similar endpoints to
Cystic kidney disease
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the urinary system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7148 | 3396 | 3699 |
| Only index persons | 5893 | 2890 | 3003 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.10 | 0.10 |
| Only index persons | 0.11 | 0.11 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 47.37 | 45.55 | 48.78 |
| Only index persons | 47.88 | 46.08 | 49.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1187 | 603 | 584 |
| Unadjusted period prevalence (%) | 0.23 | 0.21 | 0.26 |
| Median age at first event (years) | 50.16 | 48.14 | 52.24 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1072
- Matched controls
- 10720
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
97.5
323.0
433
74
Z94.0
ICD-10 Finland
Kidney transplant status
162.8
323.0
400
39
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
+∞
323.0
463
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
183.7
323.0
331
26
127
Kela drug reimbursment
Transplant complication
100.2
323.0
374
57
A11CC03
ATC
alfacalcidol; systemic
71.9
323.0
420
95
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
16384.0
323.0
712
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
113.2
323.0
479
76
TK800
NOMESCO Finland
Hemodialysis
69.3
307.2
349
74
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
140.1
306.5
317
32
A12AA04
ATC
calcium carbonate; oral
87.9
297.7
326
53
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
143.1
290.3
300
29
L04AA06
ATC
mycophenolic acid; systemic
59.8
280.1
327
78
Z49.1
ICD-10 Finland
Extracorporeal dialysis
94.3
257.6
280
40
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
144.1
235.9
245
22
N18.8
ICD-10 Finland
Other chronic renal failure
40.8
228.4
289
96
N18.0
ICD-10 Finland
End-stage renal disease
96.4
226.5
246
33
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
21.9
225.3
345
227
205
Kela drug reimbursment
Chronic hypertension
7.8
201.6
633
1668
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.9
201.0
474
792
B03XA02
ATC
darbepoetin alfa; parenteral
46.2
200.9
247
69
Z49.0
ICD-10 Finland
Preparatory care for dialysis
95.7
197.4
215
28
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
116.9
187.8
200
21
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.8
175.9
326
328
L04AD01
ATC
ciclosporin; systemic
39.3
175.1
223
71
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
63.0
165.6
192
37
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
116.8
164.9
176
18
C03CA01
ATC
furosemide; systemic
6.3
156.8
554
1553
137
Kela drug reimbursment
Uraemia requiring dialysis
71.9
154.1
175
29
Q61.99
ICD-10 Finland
Cystic kidney disease, unspecified
+∞
152.9
143
*
H02AB04
ATC
methylprednisolone; systemic
7.4
148.2
420
861
Q61.0
ICD-10 Finland
Congenital single renal cyst
+∞
144.1
135
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
28.3
140.1
194
83
C08CA01
ATC
amlodipine; oral
5.1
133.3
614
2218
V03AE01
ATC
polystyrene sulfonate; oral
60.0
128.2
150
29
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.3
127.3
257
291
V03AE02
ATC
sevelamer; oral
136.6
125.3
132
11
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
13.7
124.2
226
205
B05DA
ATC
Isotonic solutions
84.0
119.6
133
18
Z49.2
ICD-10 Finland
Other dialysis
72.5
112.7
128
20
B03XA01
ATC
erythropoietin; parenteral
60.8
106.3
124
23
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
84.6
102.6
114
15
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
83.8
101.5
113
15
196
Kela drug reimbursment
Paricalcitol and cinacalcet
115.0
96.9
104
10
B05DB
ATC
Hypertonic solutions
90.5
96.1
106
13
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
6.0
92.8
292
630
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
+∞
92.0
87
*
C09AA02
ATC
enalapril; systemic
4.7
91.9
382
1126
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
9.4
91.0
200
254
TK820
NOMESCO Finland
Peritoneal dialysis
105.3
88.6
96
10
JN3AD
NOMESCO Finland
Abdominal CT examination
7.7
86.2
216
338
Q61.1
ICD-10 Finland
Polycystic kidney, autosomal recessive
+∞
85.6
81
*
L04AA01
ATC
[U] ciclosporin; systemic
27.0
83.2
116
48
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
72.6
81.9
93
14
C08CA02
ATC
felodipine; oral
6.6
81.1
229
422
H05BX01
ATC
cinacalcet; oral
87.2
79.4
88
11
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
70.0
78.9
90
14
C07AG02
ATC
carvedilol; oral
8.5
77.9
181
249
KAC00
NOMESCO Finland
Nephrectomy
54.4
75.8
90
18
V03AE03
ATC
lanthanum carbonate; oral
109.4
75.0
81
8
R4110
NOMESCO Finland
Physiotherapy
3.5
70.5
444
1804
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
69.5
548
2623
C02AC05
ATC
moxonidine; oral
9.4
69.5
151
184
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.7
68.8
218
458
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.5
68.6
227
502
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.2
68.5
178
288
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
18.2
67.7
107
65
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.2
67.4
232
536
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
66.7
601
3129
C08CA13
ATC
lercanidipine; oral
4.6
65.9
265
721
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
122.8
64.7
69
6
J01MA02
ATC
ciprofloxacin; systemic
3.0
62.7
536
2655
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
60.1
62.6
73
13
Q44.6
ICD-10 Finland
Cystic disease of liver
219.1
60.8
62
*
M04AA01
ATC
allopurinol; systemic
4.5
59.7
243
662
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
58.7
431
1898
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
76.6
57.8
65
9
ZXE20
NOMESCO Finland
More than three and less than five hours
4.0
57.0
268
832
Q61.5
ICD-10 Finland
Medullary cystic kidney
+∞
56.8
54
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.4
55.5
140
214
I10
ICD-10 Finland
Essential (primary) hypertension
2.8
55.1
689
4204
Z2446
NOMESCO Finland
Social worker
5.2
54.7
185
412
U14
ICPC
Kidney symptom/complaint
22.1
53.1
78
38
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
10.1
52.7
108
117
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
10.5
52.1
105
110
R50.9
ICD-10 Finland
Fever, unspecified
3.7
50.8
261
864
Q61.8
ICD-10 Finland
Other cystic kidney diseases
+∞
50.4
48
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
113.6
50.3
54
5
N28.1
ICD-10 Finland
Cyst of kidney
18.8
49.6
77
44
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
73.6
49.6
56
8
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
261.9
49.5
50
*
3AC01
NOMESCO Finland
NA
20.8
49.5
74
38
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
133.7
48.2
51
*
C07AB02
ATC
metoprolol; systemic
3.2
47.8
307
1198
321
Kela drug reimbursment
Paricalcitol and cinacalcet
50.0
47.5
57
12
KBV00
NOMESCO Finland
Insertion of stent into ureter
30.3
47.1
63
22
N19
ICD-10 Finland
Unspecified kidney failure
10.0
47.0
97
106
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.2
46.8
134
242
ZXA00
NOMESCO Finland
Right side
2.8
46.7
386
1778
WX610
NOMESCO Finland
Patient controlled analgesia
33.4
45.9
60
19
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.3
45.6
98
115
TK810
NOMESCO Finland
Hemofiltration
31.7
45.4
60
20
ZXD05
NOMESCO Finland
Urgent procedure
2.7
45.2
427
2119
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
+∞
44.1
42
*
Z3226
NOMESCO Finland
Physiotherapist
3.1
43.8
299
1204
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
43.8
412
2032
J01MA12
ATC
levofloxacin; systemic
3.2
43.4
272
1033
RD210
NOMESCO Finland
NA
10.0
42.4
87
94
ZX120
NOMESCO Finland
Intravenous
4.0
42.0
185
529
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
13.4
41.3
73
58
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
41.0
176
491
WX202
NOMESCO Finland
Supraclavicular plexus blockade
13.8
39.6
69
53
XPX08
NOMESCO Finland
Intraoperative flow measurement
24.5
39.6
56
24
C02EA02
ATC
NA
6.8
39.4
103
164
C02CA01
ATC
prazosin; oral
14.5
39.3
67
49
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
39.3
241
892
R31
ICD-10 Finland
Unspecified haematuria
4.0
39.2
171
483
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
142.0
39.0
41
*
Z99.2
ICD-10 Finland
Dependence on renal dialysis
142.0
39.0
41
*
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
47.9
38.1
46
10
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.0
37.8
265
1072
Z3231
NOMESCO Finland
Registered nurse
2.5
36.2
385
1984
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
35.7
290
1282
K76.80
ICD-10 Finland
Hepatic cyst
22.2
35.1
51
24
L04AX01
ATC
azathioprine; systemic
5.3
34.8
111
227
KAC10
NOMESCO Finland
Total nephrectomy with capsule
21.8
34.2
50
24
A41.9
ICD-10 Finland
Sepsis, unspecified
7.0
34.2
87
133
R4190
NOMESCO Finland
Nutritional therapy
5.7
34.2
103
197
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
37.3
33.9
43
12
ZXE00
NOMESCO Finland
One hour or less
2.2
33.9
493
2943
C09CA01
ATC
losartan; oral
2.6
33.6
302
1407
A12BA01
ATC
potassium chloride; oral
6.4
33.6
91
152
M01AE01
ATC
ibuprofen; systemic, rectal
0.4
33.5
641
8297
RS220
NOMESCO Finland
NA
10.6
33.5
66
66
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
27.6
33.0
45
17
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
32.3
470
2786
N25.0
ICD-10 Finland
Renal osteodystrophy
63.8
32.2
37
6
C09CA06
ATC
candesartan; oral
2.6
31.9
281
1292
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
164.8
30.8
32
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
310.8
30.0
30
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
10.9
29.5
57
55
WX203
NOMESCO Finland
Infraclavicular plexus blockade
7.1
29.2
73
109
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
28.9
416
2417
UKC02
NOMESCO Finland
Cystoscopy
2.8
28.9
214
881
WX402
NOMESCO Finland
General anaesthesia
2.6
28.6
250
1132
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
28.3
347
1869
Q61.40
ICD-10 Finland
Renal dysplasia of a kidney (multicystic)
+∞
28.2
27
*
Q61
ICD-10 Finland
Cystic kidney disease
+∞
28.2
27
*
5AB14
NOMESCO Finland
NA
40.2
28.2
35
9
L57.0
ICD-10 Finland
Actinic keratosis
3.6
28.1
137
421
WW200
NOMESCO Finland
Immunization
6.1
28.0
79
139
XF612
NOMESCO Finland
Measurement of central venous pressure
102.8
27.8
30
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.2
27.8
90
187
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
27.6
276
1341
K65.0
ICD-10 Finland
Acute peritonitis
15.0
27.6
46
32
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.9
27.5
70
107
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
31.0
27.3
36
12
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.9
27.2
179
682
M10.9
ICD-10 Finland
Gout, unspecified
4.1
27.2
111
292
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.9
27.2
63
84
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.6
27.0
98
230
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
99.3
26.8
29
*
H05BX02
ATC
paricalcitol; systemic
143.6
26.7
28
*
C08CA05
ATC
nifedipine; systemic
4.0
26.5
111
299
WX002
NOMESCO Finland
Sedation and analgesia
2.4
26.2
255
1220
ZXA05
NOMESCO Finland
Left side
2.3
26.1
312
1649
Z2221
NOMESCO Finland
Medical doctor
2.2
25.8
348
1940
B01AB10
ATC
tinzaparin; parenteral
3.9
25.3
111
311
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
59.5
25.1
29
5
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
39.9
25.0
31
8
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
39.9
25.0
31
8
C10AA05
ATC
atorvastatin; oral
2.0
24.8
419
2562
L04AA05
ATC
[U] tacrolimus; systemic
255.8
24.8
25
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
92.3
24.8
27
*
M10.3
ICD-10 Finland
Gout due to impairment of renal function
32.9
24.7
32
10
N02AX02
ATC
tramadol; systemic, rectal
2.0
24.2
471
3039
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
69.1
23.9
27
*
Z94.4
ICD-10 Finland
Liver transplant status
27.4
23.7
32
12
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
15.7
23.4
38
25
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
23.4
226
1067
C10AA04
ATC
fluvastatin; oral
3.4
23.1
118
375
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
13.4
23.1
40
31
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
+∞
23.0
22
*
Q61.48
ICD-10 Finland
Nonspecified renal dysplasia
+∞
23.0
22
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
9.3
23.0
48
54
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
13.9
22.9
39
29
3025
Kela drug reimbursment
Calcium carbonate
30.8
22.9
30
10
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.8
22.3
100
285
TQW99
NOMESCO Finland
Other minor procedure on skin
4.2
22.3
87
219
JAF10
NOMESCO Finland
Repair of umbilical hernia
7.5
22.2
53
74
7151
FHL
Kidney transplantation
53.2
22.2
26
5
M01AH05
ATC
etoricoxib; oral
0.5
21.7
302
4637
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.3
21.3
82
204
WX204
NOMESCO Finland
Axillary plexus blockaced
4.9
21.2
71
153
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
4.0
21.0
86
227
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
18.3
21.0
32
18
Q61.41
ICD-10 Finland
Renal dysplasia of both kidneys (multicystic)
+∞
20.9
20
*
C09BA02
ATC
enalapril and diuretics; systemic
3.1
20.9
119
409
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
112.2
20.6
22
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
20.4
148
595
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
20.0
468
3157
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
58.7
20.0
23
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
36.5
19.9
25
7
A41.8
ICD-10 Finland
Other specified sepsis
7.7
19.8
46
62
Z31.5
ICD-10 Finland
Genetic counselling
3.9
19.8
84
229
I15.0
ICD-10 Finland
Renovascular hypertension
25.1
19.6
27
11
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
40.9
19.6
24
6
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.3
19.4
199
963
WX892
NOMESCO Finland
Monitored bed care
3.1
19.3
114
400
RS222
NOMESCO Finland
NA
10.1
19.2
38
39
C03AA03
ATC
hydrochlorothiazide; oral
2.9
19.1
122
451
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
13.1
19.0
33
26
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
5.7
19.0
55
101
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.0
18.8
112
396
H26.3
ICD-10 Finland
Drug-induced cataract
14.5
18.6
31
22
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
14.5
18.6
31
22
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.2
18.6
45
65
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
15.4
18.5
30
20
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
18.5
63
139
WW500
NOMESCO Finland
Blood transfusion
4.3
18.5
69
167
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
18.3
125
482
Z94.1
ICD-10 Finland
Heart transplant status
44.8
18.3
22
5
A07AA09
ATC
vancomycin; oral
9.5
18.2
37
40
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
53.5
18.0
21
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
13.3
18.0
31
24
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.2
17.8
69
173
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
10.6
17.7
34
33
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
7.9
17.7
40
52
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
8.5
17.6
38
46
602
Kela drug reimbursment
Children's severe malnutrition
13.4
17.5
30
23
C08CA03
ATC
isradipine; systemic
9.3
17.5
36
40
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
24.5
17.4
24
10
A02BC01
ATC
omeprazole; systemic
1.9
16.8
293
1756
UJF32
NOMESCO Finland
Coloscopy
2.0
16.8
266
1540
Q61.90
ICD-10 Finland
Meckel-Gruber syndrome
+∞
16.7
16
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.9
16.7
108
401
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
28.0
16.5
22
8
XF602
NOMESCO Finland
Bloodpressure monitoring
8.8
16.5
35
41
XF600
NOMESCO Finland
Bloodpressure measurement
3.0
16.5
99
351
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
11.9
16.1
29
25
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
6.6
16.1
41
64
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
16.0
90
304
PA2AG
NOMESCO Finland
Restrected MRI examination of vessels in the head with high intensity magnet
24.9
16.0
22
9
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.8
15.8
107
410
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
15.7
107
411
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
17.5
15.7
24
14
KH1AD
NOMESCO Finland
CT of urinary organs
4.5
15.6
55
126
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
19.6
15.6
23
12
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
10.3
15.5
30
30
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.2
15.2
47
94
306
Kela drug reimbursment
Erythropoietin and darbepoetin
23.8
15.1
21
9
C08CA10
ATC
nilvadipine; oral
6.0
14.9
41
71
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
12.7
14.9
26
21
M01AC06
ATC
meloxicam; systemic, rectal
0.5
14.9
149
2597
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
57.5
14.8
17
*
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
57.5
14.8
17
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
14.7
196
1052
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
14.6
14
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
9.0
14.5
30
34
WX882
NOMESCO Finland
High dependency care
3.9
14.5
60
161
A10BH05
ATC
linagliptin; oral
3.6
14.5
65
187
J01DB01
ATC
cefalexin; oral
1.8
14.4
847
7259
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
14.3
366
2470
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
14.3
240
1409
J01CA04
ATC
amoxicillin; systemic
1.8
14.3
858
7384
N04BC05
ATC
pramipexole; oral
2.8
14.2
92
344
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
6.8
14.1
35
53
204
Kela drug reimbursment
Leukemia lymphatica
4.2
14.1
54
135
R11
ICD-10 Finland
Nausea and vomiting
2.6
14.1
105
427
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
11.1
14.0
26
24
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
10.2
14.0
27
27
J01FF01
ATC
clindamycin; systemic
1.8
13.9
281
1757
K65.9
ICD-10 Finland
Peritonitis, unspecified
30.5
13.9
18
6
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.3
13.9
42
82
B07.9
ICD-10 Finland
Verruca simplex
3.7
13.9
60
167
ZXC50
NOMESCO Finland
Cryotherapy
4.4
13.9
50
118
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.6
13.8
63
184
K05.30
ICD-10 Finland
Periodontitis complex
2.2
13.7
142
682
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
13.7
232
1363
C07AB07
ATC
bisoprolol; oral
1.7
13.6
450
3256
KBV10
NOMESCO Finland
Removal of stent from ureter
11.1
13.5
25
23
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
34.5
13.5
17
5
PC6DE
NOMESCO Finland
NA
141.7
13.5
14
*
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
141.7
13.5
14
*
JN4AD
NOMESCO Finland
Body CT examination
2.7
13.4
91
350
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
3.0
13.3
76
262
V03AG01
ATC
sodium cellulose phosphate; systemic
28.8
13.0
17
6
4AA09
NOMESCO Finland
NA
50.6
12.9
15
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
12.8
93
370
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.8
12.7
42
91
RJ411
NOMESCO Finland
NA
12.5
12.6
22
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.0
12.6
73
254
I51.1
ICD-10 Finland
Rupture of chordae tendineae, not elsewhere classified
70.7
12.6
14
*
XX3ZW
NOMESCO Finland
NA
70.7
12.6
14
*
N18
ICD-10 Finland
Chronic kidney disease
8.9
12.5
26
30
J01MA14
ATC
moxifloxacin; systemic
2.5
12.5
104
449
E21.2
ICD-10 Finland
Other hyperparathyroidism
20.3
12.5
18
9
D638, N189
ICD-10 Finland
NA
131.5
12.5
13
*
KA5AT
NOMESCO Finland
Puncture of kidney cyst with ultrasound guidance
131.5
12.5
13
*
K06.18
ICD-10 Finland
Another gingival hyperplasia
11.8
12.3
22
19
J01EA01
ATC
trimethoprim; systemic
1.8
12.3
234
1425
N02BE01
ATC
paracetamol; systemic, rectal
1.7
12.3
869
7611
G04CA02
ATC
tamsulosin; oral
1.8
12.2
225
1355
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
16.1
12.2
19
12
KA3EB
NOMESCO Finland
Antegrade pyelography
18.3
12.1
18
10
WW400
NOMESCO Finland
Plasmaferesis
27.0
12.1
16
6
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
27.0
12.1
16
6
RS221
NOMESCO Finland
NA
5.6
12.0
34
62
RS321
NOMESCO Finland
NA
47.2
11.9
14
*
C02DE10
ATC
NA
8.0
11.9
26
33
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
11.8
113
525
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
6.4
11.7
30
48
G63.8*N18.8
ICD-10 Finland
Uraemic neuropathy
65.7
11.6
13
*
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
11.5
123
599
GD1UN
NOMESCO Finland
Lung circulation SPECT
10.2
11.5
22
22
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
+∞
11.5
11
*
Q62.10
ICD-10 Finland
Congenital unilateral occlusion of the pelvic ureteral junction
+∞
11.5
11
*
Q62.2
ICD-10 Finland
Congenital megaloureter
+∞
11.5
11
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
11.3
100
446
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
9.0
11.3
23
26
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
11.2
118
572
40399
ICD-8 Finland
Hypertensive renal disease
25.3
11.2
15
6
EB1WA
NOMESCO Finland
NA
8.2
11.1
24
30
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
9.3
11.0
22
24
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.2
11.0
41
101
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
4.2
11.0
41
101
212
Kela drug reimbursment
Gout
5.4
10.9
32
61
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
43.8
10.9
13
*
SPAT1255
SPAT
Intravenous administration of medicine
2.7
10.9
75
291
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
10.8
97
436
JJC00
NOMESCO Finland
Allogenic transplantation of liver
28.3
10.7
14
5
L01BB01
ATC
NA
21.7
10.7
15
7
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
21.7
10.7
15
7
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
21.7
10.7
15
7
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.5
10.6
81
334
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
10.6
68
254
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.6
10.6
47
135
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
10.6
147
798
B01AC04
ATC
clopidogrel; oral
2.0
10.6
147
799
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
8.6
10.6
22
26
RJ420
NOMESCO Finland
NA
14.4
10.5
17
12
D638, N180
ICD-10 Finland
NA
111.1
10.4
11
*
3008
Kela drug reimbursment
Tolvaptan
+∞
10.4
10
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
10.4
10
*
KB1BG
NOMESCO Finland
MRI examination of urinary tract with high intensity magnet
+∞
10.4
10
*
Q60.2
ICD-10 Finland
Renal agenesis, unspecified
+∞
10.4
10
*
N20.0
ICD-10 Finland
Calculus of kidney
5.0
10.4
32
65
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.7
10.4
34
74
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
10.4
98
450
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
32.9
10.3
13
*
ZX197
NOMESCO Finland
NA
32.9
10.3
13
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
7.6
10.2
23
31
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.4
10.2
49
151
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
10.2
10.0
19
19
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
14.7
10.0
16
11
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
40.5
10.0
12
*
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
40.5
10.0
12
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.3
10.0
94
434
B01AA03
ATC
warfarin; systemic
1.8
9.9
180
1074
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.8
9.8
61
224
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.7
9.7
244
1606
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
9.7
405
3031
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
55.5
9.7
11
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
9.7
68
268
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
7.9
9.6
21
27
H02AB09
ATC
hydrocortisone; systemic
3.8
9.6
39
105
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
5.3
9.6
28
54
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.7
9.5
242
1595
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
15.2
9.5
15
10
C08DB01
ATC
diltiazem; oral
2.8
9.5
59
215
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
9.5
97
463
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.4
9.4
45
138
T82.4
ICD-10 Finland
Mechanical complication of vascular dialysis catheter
100.9
9.4
10
*
Q62.0
ICD-10 Finland
Congenital hydronephrosis
+∞
9.4
9
*
Q64.2
ICD-10 Finland
Congenital posterior urethral valves
+∞
9.4
9
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.8
9.4
30
64
GD2SN
NOMESCO Finland
Lung ventilation SPECT
8.1
9.4
20
25
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
21.9
9.4
13
6
WX110
NOMESCO Finland
Local anesthesy
1.5
9.3
696
5908
C02LM02
ATC
NA
6.8
9.2
22
33
HA1AA
NOMESCO Finland
X-ray mammography
2.4
9.1
77
336
ZX108
NOMESCO Finland
Inhalation
8.4
9.1
19
23
C10AA01
ATC
simvastatin; oral
1.5
9.1
386
2891
A12AA06
ATC
calcium lactate gluconate; oral
37.0
9.0
11
*
C02DE02
ATC
NA
5.5
8.9
25
46
J01MA06
ATC
norfloxacin; oral
1.9
8.9
132
732
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.1
8.9
33
82
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
12.7
8.9
15
12
TPX15
NOMESCO Finland
Removal of vascular injection port
12.7
8.9
15
12
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
8.7
8.8
18
21
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
10.8
8.8
16
15
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.7
8.8
37
103
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.7
86
406
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.9
8.7
27
56
I15.8
ICD-10 Finland
Other secondary hypertension
14.2
8.7
14
10
KC1JB
NOMESCO Finland
Miktiocystography with X-ray
50.4
8.7
10
*
TJA30
NOMESCO Finland
Peritoneal dialysis
50.4
8.7
10
*
M01AB05
ATC
diclofenac; systemic, rectal
0.7
8.6
441
5434
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.1
8.6
96
477
M05BA04
ATC
alendronic acid; oral
2.3
8.6
79
358
N30.0
ICD-10 Finland
Acute cystitis
1.9
8.5
127
707
N15.9
ICD-10 Finland
Renal tubulo-interstitial disease, unspecified
27.8
8.5
11
*
L04AA10
ATC
sirolimus; oral
27.8
8.5
11
*
59321
ICD-8 Finland
Other diseases of kidney and ureter, Cysta (cystis) renis (non congenita)
27.8
8.5
11
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.4
8.5
73
321
SPAT1164
SPAT
Haemodialysis
90.8
8.4
9
*
XFE00
NOMESCO Finland
Epicardial ultrasonography
4.1
8.4
31
77
C10AA03
ATC
pravastatin; oral
2.4
8.4
70
304
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
8.4
78
358
Q60.4
ICD-10 Finland
Renal hypoplasia, bilateral
+∞
8.3
8
*
Q63.1
ICD-10 Finland
Lobulated, fused and horseshoe kidney
+∞
8.3
8
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.3
8.3
24
46
C02DE04
ATC
NA
4.2
8.3
30
73
ED1AA
NOMESCO Finland
Mandipular X-ray examination
8.6
8.3
17
20
JAD10
NOMESCO Finland
Repair of incisional hernia
7.1
8.3
19
27
C09CA03
ATC
valsartan; oral
2.1
8.2
95
478
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
8.2
108
576
XQ848
NOMESCO Finland
Dermatological photography
3.7
8.2
34
94
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
8.2
42
137
K83.0
ICD-10 Finland
Cholangitis
5.2
8.2
24
47
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
7.6
8.2
18
24
WZC30
NOMESCO Finland
Teaching
1.8
8.2
135
779
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.7
8.1
26
56
5602
FHL
Internal fistula (eg Cimino)
33.6
8.1
10
*
C02DB01
ATC
dihydralazine; systemic
33.6
8.1
10
*
N15.1
ICD-10 Finland
Renal and perinephric abscess
33.6
8.1
10
*
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
3.4
8.1
37
111
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.8
8.1
136
791
40199
ICD-8 Finland
Essential benign hypertension
4.6
8.0
26
57
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.6
8.0
58
233
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.3
7.9
28
67
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.5
7.9
349
2619
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.8
500
4042
KA1FN
NOMESCO Finland
Isotope renography
8.5
7.8
16
19
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.2
7.8
38
120
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
45.3
7.7
9
*
C02CB01
ATC
NA
45.3
7.7
9
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.6
7.7
25
55
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.8
7.7
131
765
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
7.7
122
695
A02BC02
ATC
pantoprazole; systemic
1.4
7.6
604
5076
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
7.6
36
111
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
18.5
7.6
11
6
U99
ICPC
Urinary disease other
8.1
7.6
16
20
SCD02
NOMESCO Finland
Removal of tooth plaque or tartar
8.1
7.6
16
20
C09AA01
ATC
captopril; oral
4.5
7.6
25
56
RJ425
NOMESCO Finland
NA
25.2
7.6
10
*
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
25.2
7.6
10
*
K06.10
ICD-10 Finland
Gingival fibromatosis
25.2
7.6
10
*
PB1AE
NOMESCO Finland
Ultrasound examination of arteries of upper extremity
25.2
7.6
10
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
25.2
7.6
10
*
D638, N188
ICD-10 Finland
NA
25.2
7.6
10
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.5
7.5
33
96
AA1AD
NOMESCO Finland
CT of head and brain
1.6
7.5
222
1514
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.1
7.4
22
44
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.6
7.4
32
92
JA3FT
NOMESCO Finland
Exchange abdominal catheter with radiological guidance
80.6
7.4
8
*
KAS96
NOMESCO Finland
Other transplantation of kidney or related procedure
80.6
7.4
8
*
RJ530
NOMESCO Finland
NA
80.6
7.4
8
*
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
6.0
7.4
19
32
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
BE00A
NOMESCO Finland
NA
+∞
7.3
7
*
PBL11
NOMESCO Finland
Construction of arteriovenous fistula from ulnar artery
+∞
7.3
7
*
C44.01
ICD-10 Finland
Basocellular carcinoma of the lip skin
+∞
7.3
7
*
U70
ICPC
Pyelonephritis/pyelitis
6.3
7.3
18
29
S37.0
ICD-10 Finland
Injury of kidney
15.9
7.2
11
7
N28.8
ICD-10 Finland
Other specified disorders of kidney and ureter
15.9
7.2
11
7
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
7.2
161
1019
C09AA03
ATC
lisinopril; oral
2.5
7.2
54
223
C09AA05
ATC
ramipril; oral
1.6
7.2
210
1429
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
20.2
7.1
10
5
L82
ICD-10 Finland
Seborrhoeic keratosis
1.7
7.1
144
886
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
3.8
7.1
28
75
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
7.1
181
1191
N02AA05
ATC
oxycodone; systemic
1.8
7.0
124
732
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
10.1
7.0
13
13
J01MA01
ATC
ofloxacin; systemic
2.1
7.0
80
402
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
6.4
7.0
17
27
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.8
6.9
120
705
C07AG01
ATC
labetalol; systemic
5.9
6.9
18
31
2161
FHL
Neck ligation, big brain
13.9
6.9
11
8
A10BH02
ATC
vildagliptin; oral
4.2
6.8
24
58
TQW80
NOMESCO Finland
Local dermatologic skincare
3.3
6.8
32
99
UJK02
NOMESCO Finland
ERCP
3.7
6.8
28
78
PD1AE
NOMESCO Finland
Ultrasound examination of abdominal aortta
11.0
6.8
12
11
RJ421
NOMESCO Finland
NA
11.0
6.8
12
11
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
5.7
6.8
18
32
JX1XB
NOMESCO Finland
Other X-ray examination of alimentary tract with contrast
40.3
6.8
8
*
RJ120
NOMESCO Finland
NA
16.8
6.7
10
6
RJ412
NOMESCO Finland
NA
16.8
6.7
10
6
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.7
6.7
139
861
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.7
78
396
-
ICD-10 Finland
NA
3.2
6.7
33
106
J01CA08
ATC
pivmecillinam; oral
1.5
6.7
321
2434
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
6.6
16
25
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
6.5
6.6
16
25
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.3
6.6
23
55
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
6.6
59
268
N43.3
ICD-10 Finland
Hydrocele, unspecified
3.8
6.6
26
70
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
8.8
6.6
13
15
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
8.8
6.6
13
15
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
8.8
6.6
13
15
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.9
6.5
93
511
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
6.2
6.5
16
26
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
5.7
6.5
17
30
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
6.4
204
1415
RJ129
NOMESCO Finland
NA
70.3
6.4
7
*
PB1AT
NOMESCO Finland
Upper extremity artery PTA
70.3
6.4
7
*
PA2AM
NOMESCO Finland
Simple MRI examination of vessels in the head with 3 Tesla magnet
70.3
6.4
7
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.7
6.4
20
43
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
4.7
6.4
20
43
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
14.4
6.4
10
7
A05AA02
ATC
ursodeoxycholic acid; oral
3.8
6.4
25
67
XW000
NOMESCO Finland
Bone marrow biopsy
2.7
6.4
41
154
C10AX09
ATC
ezetimibe; oral
1.8
6.4
101
577
B01AB04
ATC
dalteparin; parenteral
2.4
6.4
49
207
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
6.4
67
328
H01AC01
ATC
somatropin; parenteral
6.6
6.3
15
23
XF402
NOMESCO Finland
ECG with work load test
1.8
6.3
102
583
A46
ICD-10 Finland
Erysipelas
1.7
6.3
121
735
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.2
6.3
31
100
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
6.3
119
718
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
9.3
6.3
12
13
ZQZ00
NOMESCO Finland
Treatment of several skin areas
9.3
6.3
12
13
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
9.3
6.3
12
13
K65.8
ICD-10 Finland
Other peritonitis
18.1
6.3
9
5
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
18.1
6.3
9
5
KB1DG
NOMESCO Finland
Very extensive MRI of urinary tract
+∞
6.3
6
*
TKA05
NOMESCO Finland
Aspiration cytology of kidney
+∞
6.3
6
*
N15.8
ICD-10 Finland
Other specified renal tubulo-interstitial diseases
+∞
6.3
6
*
Q61.4
ICD-10 Finland
Renal dysplasia
+∞
6.3
6
*
Q60.3
ICD-10 Finland
Renal hypoplasia, unilateral
+∞
6.3
6
*
K03.64
ICD-10 Finland
Dental calculus supragingival
1.5
6.2
266
1967
5850A
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]
26.8
6.2
8
*
BBA50
NOMESCO Finland
Total parathyroidectomy
26.8
6.2
8
*
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
26.8
6.2
8
*
PBC09
NOMESCO Finland
Suture of brachial artery
26.8
6.2
8
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.5
6.2
47
194
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
6.2
133
832
N20.1
ICD-10 Finland
Calculus of ureter
2.6
6.2
41
159
C07AB03
ATC
atenolol; systemic
2.3
6.2
56
256
K02.9
ICD-10 Finland
Dental caries, unspecified
3.8
6.1
24
65
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
6.1
80
428
RJ511
NOMESCO Finland
NA
12.6
6.1
10
8
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
4.4
6.1
20
46
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.5
6.0
44
181
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
10.1
6.0
11
11
DHB00
NOMESCO Finland
Excision of lesion of external nose
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
292
220
17.28
322.16
2.7
1.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
213
41
63.09
307.65
2.2
1.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
439
304
22.33
307.65
9.1
6.2
mg/l
1.9
1.4
16.93
430
286
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
286
204
18.15
307.65
2.6
1.4
u/ml
119.4
105.8
1.23
61
35
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
168
16
122.15
307.65
5.4
6.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
725
693
25.31
307.65
12.9
4.0
ng/l
159.1
81.5
31.85
688
625
(3010375) cycloSPORINE [Mass/volume] in Blood
233
42
68.78
307.65
28.9
29.6
ug/l
100.4
135.4
2.22
202
36
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
317
164
26.01
307.65
5.5
3.7
u/ml
1756.4
485.1
0.39
14
19
(3003458) Phosphate [Moles/volume] in Serum or Plasma
847
1306
20.15
307.65
25.7
6.0
mmol/l
1.1
1.1
8.69
841
1217
(3020779) Urea [Moles/volume] in Serum or Plasma
768
857
23.55
307.65
24.6
7.9
mmol/l
13.0
9.0
31.55
760
817
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
343
206
23.01
307.65
10.8
6.1
iu/ml
822.8
392.0
0.47
98
32
(3042733) HLA Ab [Presence] in Serum
194
32
72.27
307.65
6.2
4.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
596
1247
8.59
305.68
9.7
2.5
%
23.0
23.0
0.03
561
1090
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
393
556
10.07
281.64
14.8
4.9
mmol/l
22.7
24.0
11.99
372
514
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
272
229
15.11
280.10
1.9
1.3
u/ml
275.5
239.4
0.74
217
129
(3004789) Transferrin [Mass/volume] in Serum or Plasma
594
1340
7.87
279.88
9.5
2.4
g/l
2.0
2.3
38.66
587
1253
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
208
108
23.14
273.98
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
270
240
14.27
268.58
1.8
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
209
115
21.84
268.23
2.2
2.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
606
1464
7.41
264.34
9.5
2.4
umol/l
11.8
13.3
7.03
598
1361
(3021447) Carbon dioxide [Partial pressure] in Venous blood
490
960
7.99
262.43
14.8
4.4
kpa
5.7
5.8
0.92
484
934
(3002032) Base excess in Venous blood by calculation
486
954
7.93
259.49
15.0
4.4
mmol/l
-0.0
1.7
18.12
425
757
(3000991) Gas panel - Venous blood
462
870
8.06
256.18
16.1
8.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
696
1991
7.03
252.31
7.9
2.5
e6/l
2.5
5.7
9.51
661
1755
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
127
24
59.14
225.49
1.1
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
167
81
23.83
225.41
1.5
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
129
27
53.48
224.38
1.1
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
771
2653
6.44
220.95
10.1
3.1
e6/l
0.1
0.4
9.99
694
2011
(36304419) Bacteria [Presence] in Urine
758
2588
6.34
218.57
9.8
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
802
2882
6.50
217.90
10.7
3.2
e6/l
20.6
86.3
2.02
745
2225
(3024471) HLA-A [Type]
135
41
37.02
214.09
1.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
767
2685
6.25
213.63
22.0
3.9
ph
7.4
7.4
5.88
157
501
(3024932) HLA-DR beta [Type]
134
40
37.64
213.54
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
197
151
15.44
212.43
9.5
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
385
729
7.34
208.44
3.9
2.5
ml/min/173m2
37.6
70.3
36.84
192
290
(3024354) Oxygen [Partial pressure] in Venous blood
407
829
6.95
204.73
10.0
3.8
kpa
6.2
4.7
16.80
400
804
(3012516) Albumin [Mass/volume] in Urine
753
2668
5.98
204.44
8.3
3.3
mg/l
197.2
175.5
0.08
665
1727
(3009508) Creatinine [Moles/volume] in Urine
794
2980
6.03
200.24
8.3
3.3
mmol/l
5.8
7.9
42.86
761
2516
(3020682) Albumin/Creatinine [Ratio] in Urine
768
2808
5.92
199.63
9.6
4.0
mg/mmol
17.2
8.7
4.84
679
1794
(3048929) Epstein Barr virus Ab [Presence] in Serum
279
388
9.09
198.62
1.8
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
279
395
8.93
195.54
1.9
2.0
g/l
1.5
1.5
0.01
261
346
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
118
32
40.84
192.73
3.1
2.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
696
2412
5.56
190.77
6.7
2.7
umol/l
969.2
6028.4
4.97
669
2108
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
557
1616
5.61
188.47
6.4
2.8
e6/l
0.5
1.0
6.35
406
926
(3026782) Osmolality of Urine
601
1879
5.45
185.53
8.3
2.7
mosm/kgh2o
472.5
560.7
26.99
570
1598
(3018095) Leukocytes [#/volume] in Urine
827
3371
5.79
184.12
13.3
3.6
e6/l
35.3
89.0
2.64
759
2382
(3024561) Albumin [Mass/volume] in Serum or Plasma
897
3928
6.25
182.63
17.4
5.0
g/l
35.6
35.7
0.32
879
3668
(3012095) Magnesium [Moles/volume] in Serum or Plasma
531
1524
5.50
180.79
5.8
3.7
mmol/l
0.8
0.8
2.99
518
1427
(3014148) Varicella zoster virus Ab [Titer] in Serum
160
119
15.38
174.69
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
225
296
9.15
166.36
3.9
3.6
u/ml
0.3
0.4
4.11
98
167
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
908
4220
5.90
165.87
29.9
6.4
mmol/l
1.2
1.2
7.48
891
3833
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
946
4633
6.13
159.52
37.3
7.0
mmol/l
1.2
1.2
1.15
865
3952
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
155
132
13.36
155.87
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
500
1526
4.93
154.15
6.8
3.0
e6/l
1.4
2.0
1.35
334
837
(3017143) Hepatitis C virus Ab [Presence] in Serum
418
1117
5.23
151.38
4.3
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
184
212
10.09
150.39
7.2
4.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
815
3849
4.57
135.14
4.5
2.3
nmol/l
80.1
75.9
4.79
802
3457
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
362
938
5.11
134.38
4.2
3.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
445
1441
4.34
122.87
4.2
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
111
80
15.20
122.57
5.5
5.6
%
11.3
11.5
0.14
111
80
(3018677) aPTT in Platelet poor plasma by Coagulation assay
440
1472
4.16
115.10
3.5
2.4
s
29.6
29.7
0.13
435
1423
(3033658) Prothrombin time (PT) actual/Normal
589
2434
3.82
112.74
8.8
4.1
%
97.8
90.4
8.85
580
2379
(3011397) Hemoglobin [Presence] in Urine by Test strip
547
2194
3.77
108.70
8.6
3.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
254
577
5.33
108.38
8.8
3.8
g/l
111.2
128.9
25.31
249
569
(3027945) Reticulocytes/100 erythrocytes in Blood
347
1020
4.39
107.46
4.7
2.9
%
1.6
1.7
3.37
336
925
(3023368) Bacteria identified in Blood by Culture
594
2546
3.67
105.99
9.1
4.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
287
746
4.76
103.88
4.4
2.9
e9/l
58.1
70.5
8.13
198
563
(3035350) Ketones [Presence] in Urine by Test strip
855
4670
3.97
103.71
9.8
3.4
estimate
0.0
0.0
0.00
192
872
(3014111) Lactate [Moles/volume] in Serum or Plasma
306
842
4.55
102.95
9.2
8.0
mmol/l
1.0
1.4
5.84
296
803
(3021601) Nitrite [Presence] in Urine by Test strip
852
4668
3.92
102.26
13.3
4.7
estimate
0.0
0.0
0.50
191
887
(3014576) Chloride [Moles/volume] in Serum or Plasma
369
1184
4.07
100.66
9.8
7.3
mmol/l
103.8
104.2
0.79
364
1156
(3009261) Glucose [Presence] in Urine by Test strip
855
4724
3.90
100.63
9.8
3.4
estimate
0.0
0.0
0.80
194
847
(3009343) pH of Capillary blood
275
715
4.70
99.18
12.7
4.3
ph
7.4
7.4
0.53
63
83
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
276
721
4.68
98.93
12.8
4.3
kpa
4.9
5.1
9.36
268
678
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
268
690
4.73
97.76
12.8
4.3
mmol/l
0.2
1.8
9.84
168
506
(46235355) HIV 1 and 2 tests - Meaningful Use set
468
1798
3.65
97.36
4.2
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
671
3336
3.33
90.12
10.2
6.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
137
203
7.50
89.87
8.1
3.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
531
2313
3.34
88.76
3.6
2.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
178
355
5.72
86.98
8.6
4.5
g/l
0.3
0.3
0.09
130
168
(3042936) Bacteria identified in Isolate by Culture
379
1363
3.62
85.74
2.4
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
241
650
4.40
81.90
2.3
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
609
2994
3.12
80.88
4.0
2.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
393
1513
3.39
78.95
2.5
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
742
4187
3.06
75.09
9.0
2.7
ug/l
202.9
126.2
17.91
732
3891
(3037467) Urinalysis macro (dipstick) panel - Urine
988
6592
3.98
74.95
14.1
4.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
821
4938
3.15
73.34
11.0
5.9
e9/l
0.0
0.0
6.21
726
4290
(3001604) Monocytes [#/volume] in Blood
817
4920
3.12
72.43
11.0
5.9
e9/l
0.6
0.6
0.13
725
4263
(3032080) INR in Blood by Coagulation assay
681
3727
2.94
71.79
14.0
8.8
inr
1.2
1.2
0.18
190
1068
(3019198) Lymphocytes [#/volume] in Blood
829
5062
3.11
71.10
11.0
6.0
e9/l
1.6
2.0
5.88
739
4468
(3031040) Bacteria [#/volume] in Urine by Automated count
943
6224
3.51
70.15
10.4
4.2
e6/l
17.5
1530.0
1.08
17
89
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
810
4907
3.05
70.00
7.8
6.4
umol/l
10.2
11.6
4.03
800
4651
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
578
2928
2.90
69.95
4.1
2.6
u/l
66.9
57.1
5.73
562
2719
(3013115) Eosinophils [#/volume] in Blood
831
5117
3.08
69.47
11.4
6.3
e9/l
0.2
0.2
0.58
743
4513
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
150
314
5.32
68.97
3.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
109
170
6.96
67.85
5.1
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
539
2670
2.87
67.45
4.7
2.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
757
4496
2.89
66.46
11.7
6.1
%
0.6
0.7
2.24
745
4218
(3006504) Eosinophils/100 leukocytes in Blood
771
4638
2.89
65.79
11.7
6.0
%
2.8
2.9
0.77
757
4335
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1027
7279
4.05
65.37
18.9
7.4
u/l
80.7
80.6
0.03
1018
6853
(3019069) Monocytes/100 leukocytes in Blood
773
4670
2.88
65.16
11.9
6.3
%
8.7
8.6
0.32
761
4392
(40758558) Short blood count panel - Blood
510
2508
2.81
63.94
8.7
6.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
293
1062
3.34
63.36
2.3
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
873
5675
3.04
63.19
13.0
9.1
e9/l
4.3
4.0
2.27
780
4973
(3018010) Neutrophils/100 leukocytes in Blood
775
4733
2.84
63.17
11.3
5.9
%
61.0
56.4
23.08
762
4453
(40761535) Cells panel - Urine sediment
239
765
3.66
62.78
10.0
3.3
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
779
4803
2.81
61.73
11.7
6.1
%
24.3
28.7
25.33
765
4500
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
289
1066
3.26
60.45
2.4
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
128
265
5.29
59.37
1.8
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
727
4396
2.69
58.71
19.9
9.3
e9/l
0.0
0.0
0.20
566
3597
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
256
898
3.36
57.95
4.1
2.5
u/l
42.5
86.3
0.39
242
771
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
105
186
6.10
57.56
2.5
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
103
187
5.94
55.01
4.8
2.5
%
16.7
16.3
0.37
92
102
(3013826) Glucose [Moles/volume] in Serum or Plasma
839
5589
2.71
53.29
13.4
5.0
mmol/l
6.5
6.7
2.75
821
5235
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
718
4461
2.54
52.45
5.8
4.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
50
39
13.34
52.25
1.2
1.0
miu/ml
1635.5
1574.4
0.10
50
39
(3030981) Hyaline casts [#/volume] in Urine by Automated count
166
470
3.94
51.64
7.0
2.7
e6/l
0.0
0.2
4.41
159
456
(3015377) Calcium [Moles/volume] in Serum or Plasma
556
3107
2.49
50.64
7.7
3.4
mmol/l
2.3
2.4
0.73
526
2738
(3021879) Hepatitis B virus core Ab [Presence] in Serum
215
734
3.36
50.37
3.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
125
294
4.63
49.65
5.4
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
177
540
3.68
49.32
15.6
4.4
—
—
—
0
0
(4035726)
221
788
3.22
48.06
1.7
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
65
84
8.13
47.58
1.9
2.1
g/24h
1.1
1.4
—
5
7
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
80
132
6.43
46.96
6.5
6.2
mg/l
11.8
11.1
0.44
72
121
(3006184) Hemoglobin [Mass/volume] in Capillary blood
100
209
5.13
45.67
4.1
2.4
g/l
128.7
130.8
0.34
94
156
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
173
547
3.53
45.51
2.2
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
202
718
3.19
43.93
2.6
2.9
g/l
64.1
66.8
5.14
193
660
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
443
2359
2.40
43.34
3.0
2.2
mg/l
2.8
3.0
1.03
393
2021
(3012501) Base excess in Blood by calculation
94
195
5.15
43.26
8.4
4.3
mmol/l
1.8
2.5
1.51
52
130
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
110
261
4.54
43.09
1.7
3.6
ratio
1.5
1.9
—
5
24
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
110
264
4.49
42.47
1.7
3.7
mg/l
67.3
44.0
0.98
80
213
(3034860) Kappa light chains.free [Mass/volume] in Serum
110
264
4.49
42.47
1.7
3.7
mg/l
82.0
78.6
0.05
79
212
(3049717) Cytology report of Urine Cyto stain
129
357
3.93
41.16
2.1
2.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
150
467
3.53
40.23
6.6
11.2
mmol/l
22.6
24.5
8.90
145
440
(3029937) Albumin [Presence] in Urine by Test strip
450
2479
2.31
40.05
11.0
3.7
estimate
0.0
0.0
0.24
178
854
(3010421) pH of Blood
100
240
4.46
38.55
9.1
4.0
ph
7.4
7.4
4.73
94
192
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
109
282
4.15
38.09
1.8
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
89
197
4.80
37.90
1.5
3.9
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
63
106
6.22
36.20
1.3
1.2
u/l
81.2
54.7
1.07
41
78
(3019309) Folate [Moles/volume] in Red Blood Cells
322
1599
2.39
35.79
1.9
1.7
nmol/l
1299.4
1183.8
1.06
279
1216
(3003396) Base excess in Arterial blood by calculation
237
1029
2.63
35.07
7.7
8.5
mmol/l
-1.0
1.1
10.13
188
821
(3027801) Oxygen [Partial pressure] in Arterial blood
237
1034
2.61
34.70
7.7
8.5
kpa
12.0
12.4
0.52
231
997
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
237
1034
2.61
34.70
7.7
8.5
kpa
5.1
5.1
0.06
229
994
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
157
551
3.13
34.50
1.9
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
569
3606
2.11
34.22
10.2
3.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
74
153
5.09
34.11
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
213
902
2.66
33.01
2.7
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
93
238
4.15
32.91
5.7
2.3
ug/min
139.0
94.6
0.52
80
138
(3003694) ABO and Rh group [Type] in Blood
458
2713
2.12
32.52
1.7
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
248
1143
2.48
32.15
2.4
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
214
926
2.60
31.66
8.1
9.0
%
94.2
95.8
1.96
209
896
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
35
5
71.91
31.03
3.0
4.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
54
96
5.85
29.32
6.5
3.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
33
5
67.75
29.04
3.0
4.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
116
380
3.27
28.45
2.6
1.9
ug/l
3.8
2.1
0.58
110
339
(3021960) Folate [Moles/volume] in Serum or Plasma
373
2134
2.09
28.27
1.9
1.5
nmol/l
20.4
20.4
0.01
348
1811
(3025315) Body weight
33
6
56.49
28.26
4.0
3.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
45
69
6.74
28.24
7.2
3.7
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
21
10
21.36
27.71
2.0
1.7
ng/l
155.0
102.7
—
21
10
(3017817) Protein [Mass] in Urine collected for unspecified duration
49
85
5.97
27.27
2.4
2.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
78
205
4.00
26.57
1.9
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
78
205
4.00
26.57
1.9
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
230
1110
2.33
26.47
5.9
3.1
umol/l
6.5
8.1
0.89
211
977
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
39
55
7.30
26.40
4.2
3.4
%
92.6
100.2
0.64
39
55
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
81
220
3.88
26.36
1.6
1.7
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
29
5
59.38
25.09
3.3
2.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
147
591
2.70
24.92
1.6
2.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
39
59
6.80
24.77
1.3
1.2
u/l
26.9
17.0
1.13
33
51
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
58
128
4.71
24.73
3.0
2.1
—
1506.7
—
0
6
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
69
176
4.10
24.47
1.8
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
62
147
4.40
24.19
1.8
1.6
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
39
61
6.58
24.01
1.3
1.1
u/l
190.2
80.9
0.50
34
54
(3036489) Thrombin time
111
393
3.01
23.80
3.0
2.8
s
21.8
21.5
0.26
103
354
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
192
898
2.36
23.57
3.7
2.5
g/l
0.2
0.2
2.10
185
840
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
81
239
3.56
23.35
1.7
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
410
2568
1.91
23.12
8.4
3.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
537
3695
1.83
22.26
2.2
1.9
pmol/l
97.2
94.8
0.57
320
1944
(3030905) Polymorphonuclear cells [#/volume] in Blood
68
186
3.82
21.90
3.8
3.7
e9/l
3.8
4.3
1.01
68
186
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
428
2776
1.85
21.25
2.1
2.2
u/l
178.7
263.4
1.17
417
2622
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
77
236
3.42
20.94
1.8
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
68
192
3.70
20.92
4.0
3.9
%
57.9
57.0
0.25
68
192
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
45
93
4.99
20.73
8.5
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
121
484
2.67
20.62
8.3
11.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
473
3197
1.80
20.28
4.8
3.4
u/l
31.8
33.3
0.19
464
3058
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
19
14
13.78
20.25
1.9
4.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
24
5
48.91
20.21
2.5
5.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
339
2090
1.87
19.47
9.7
3.7
kg/l
1.0
1.0
0.77
40
301
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1042
9020
2.27
19.36
39.7
12.2
ml/min/173m2
52.1
83.3
144.76
964
7393
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
48
114
4.35
18.70
1.9
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
123
521
2.52
18.61
1.5
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
155
732
2.29
18.39
6.1
4.5
%
0.1
0.1
0.04
69
212
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
390
2548
1.79
18.34
2.1
1.7
mmol/l
1.4
1.4
0.01
369
2154
(3017181) Myelocytes/100 leukocytes in Blood
161
774
2.25
18.31
6.0
4.4
%
0.9
0.8
0.07
74
235
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1098
9778
2.64
18.16
46.1
13.4
mg/l
24.3
24.2
0.04
1019
7639
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
46
6.44
17.61
1.3
5.2
mg/l
4122.1
82.6
0.48
29
35
(3002179) Metamyelocytes/100 leukocytes in Blood
149
708
2.26
17.39
5.6
4.2
%
0.8
0.4
1.31
55
173
(3025159) Blasts/100 leukocytes in Blood
146
688
2.28
17.38
6.0
4.5
%
0.0
0.6
0.61
62
182
(3045414) Leukocytes [Presence] in Urine
101
407
2.62
16.91
2.9
1.8
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
20
24
8.46
15.41
1.3
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
377
2540
1.71
15.39
3.0
3.1
ng/l
5427.8
1236.6
8.28
341
2161
(3000570) Elastase.pancreatic [Mass/mass] in Stool
77
285
2.82
15.20
1.3
1.4
ug/g
295.0
300.7
0.08
48
173
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1003
8757
1.94
15.17
9.6
5.6
mmol/mol
38.3
39.7
5.77
982
8131
(3019550) Sodium [Moles/volume] in Serum or Plasma
1099
9940
2.42
14.89
56.5
15.4
mmol/l
139.5
139.7
1.02
1091
9684
(3045424) Erythrocytes [Presence] in Urine
53
161
3.40
14.63
1.5
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
67
4.88
14.54
1.9
1.5
u/l
6.1
7.0
0.10
18
35
(3023103) Potassium [Moles/volume] in Serum or Plasma
1100
9973
2.40
14.47
59.0
15.5
mmol/l
4.1
4.0
35.67
1092
9696
(3022217) INR in Platelet poor plasma by Coagulation assay
194
1094
1.92
14.21
30.7
23.5
inr
1.3
1.3
0.12
25
150
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1027
9088
1.96
14.18
6.6
3.9
mmol/l
1.4
1.3
4.32
1001
8376
(40761536) Microorganisms panel - Urine sediment
153
795
2.06
14.14
13.9
3.7
—
—
—
0
0
(3002256) Pathology report gross observation
204
1176
1.89
13.96
1.5
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
26
47
5.63
13.87
1.7
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
26
47
5.63
13.87
1.7
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
480
3523
1.61
13.64
4.6
3.5
ng/l
42.2
50.3
0.31
393
2387
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
17
5
34.46
13.52
4.9
5.2
umol/l
490.2
392.6
—
17
5
(3020891) Body temperature
87
370
2.46
13.02
9.1
4.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
71
274
2.69
12.96
1.8
2.6
g/l
0.3
1.1
2.11
65
245
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
144
766
2.00
12.43
2.3
2.3
ug/l
4.7
7.4
2.84
131
681
(3044889) 12 lead EKG panel
797
6670
1.59
12.35
4.8
3.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
77
317
2.53
12.35
2.6
2.9
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
18
25
7.30
12.29
2.1
2.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
165
926
1.91
12.17
2.9
2.1
nmol/l
354.1
368.3
0.41
160
861
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
19
29
6.64
11.94
14.1
7.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
492
3718
1.55
11.85
2.7
2.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
112
3.57
11.76
3.7
3.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1044
9420
1.90
11.71
7.3
4.3
mmol/l
1.4
1.4
4.18
1019
8710
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
313
2.49
11.69
1.8
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
313
2.49
11.69
1.8
2.4
g/l
3.7
3.8
0.03
61
235
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
313
2.49
11.69
1.8
2.4
g/l
7.6
7.3
0.43
63
246
(3000093) Morphology [Interpretation] in Blood Narrative
31
76
4.16
11.64
1.3
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
943
8272
1.68
11.59
50.5
16.4
%
14.0
13.6
11.76
933
8105
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
296
2.52
11.59
1.8
2.4
g/l
3.3
3.1
1.16
62
238
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
71
290
2.54
11.58
1.8
2.4
g/l
9.7
10.9
1.54
65
253
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
23
44
5.31
11.56
1.7
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
23
44
5.31
11.56
1.7
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
265
1741
1.67
11.39
3.8
3.7
ng/l
815.6
520.5
0.50
223
1318
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
53
188
2.90
11.34
1.4
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
42
130
3.31
11.30
1.5
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1047
9482
1.88
11.23
7.4
4.3
mmol/l
4.4
4.7
21.46
1023
8819
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
37
106
3.57
11.20
1.2
1.4
pmol/l
466.2
320.6
0.71
32
89
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
28
6.51
11.11
13.6
7.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
30
75
4.08
10.98
2.1
1.7
—
—
—
0
0
(44790049)
40
123
3.33
10.88
1.5
1.6
—
—
—
0
0
(44806118)
40
123
3.33
10.88
1.5
1.6
—
—
—
0
0
(44790047)
40
123
3.33
10.88
1.5
1.6
—
—
—
0
0
(44790048)
40
123
3.33
10.88
1.5
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
773
6521
1.53
10.70
5.6
3.2
u/l
53.6
49.2
0.73
758
6128
(3005719) IgG [Mass/volume] in Serum or Plasma
141
783
1.91
10.70
2.6
2.8
g/l
9.5
10.5
2.28
135
724
(3019225) pH of Specimen
156
902
1.84
10.44
26.0
4.1
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
10
0
+∞
10.43
9.2
0.0
ug/l
7.1
—
—
10
0
(3000494) Fungus identified in Specimen by Culture
191
1174
1.75
10.41
1.7
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
770
6512
1.52
10.35
3.5
3.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
17
27
6.37
10.29
1.8
2.4
e6/l
5608.0
4532.9
0.12
12
16
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
15
8
18.97
10.27
3.1
5.3
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
21
42
5.07
10.07
3.6
2.7
u/ml
260.0
55857.9
—
5
8
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
81
376
2.24
9.96
2.5
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
49
180
2.80
9.86
1.3
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
70
309
2.34
9.68
1.7
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
75
342
2.27
9.62
2.3
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
37
118
3.20
9.52
1.5
1.3
nmol/l
0.7
0.6
0.58
37
111
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
43
150
2.94
9.51
1.5
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
17
7.72
9.29
1.3
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
171
1051
1.73
9.27
1.4
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1049
9629
1.77
9.07
7.6
4.8
mmol/l
2.5
2.8
26.70
1025
8909
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
36
117
3.14
9.00
1.5
1.3
nmol/l
0.3
0.5
—
5
8
(3009871) Measles virus Ab [Titer] in Serum
17
32
5.38
8.70
1.8
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
176
2.68
8.60
1.5
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
52
212
2.52
8.57
1.8
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
37
126
3.00
8.56
2.1
1.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
42
155
2.77
8.42
1.3
1.2
u/ml
2.0
5.6
1.56
17
66
(40760892) CBC W Ordered Manual Differential panel - Blood
303
2192
1.51
8.33
8.5
4.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
54
228
2.43
8.27
2.2
3.6
umol/l
27.7
35.3
2.87
41
191
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
35
118
3.03
8.24
2.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
140
2.85
8.23
1.5
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
48
194
2.54
8.06
1.8
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
120
2.97
8.01
2.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
35
120
2.97
8.01
2.0
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1092
10213
1.86
7.91
41.0
12.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
70
337
2.14
7.90
1.3
1.5
g/l
1.1
1.2
1.03
70
319
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
32
105
3.10
7.90
1.6
1.3
nmol/l
—
—
—
0
0
(3019060) Gas panel - Arterial blood
106
592
1.87
7.90
7.5
5.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
21
52
4.09
7.82
3.2
1.8
—
46.2
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
33
112
3.00
7.70
1.5
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
809
7095
1.44
7.68
5.8
4.0
mm/h
19.4
11.5
20.63
773
6565
(3020393) Adenovirus Ag [Presence] in Stool
12
18
6.72
7.61
3.3
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
29
92
3.21
7.57
1.4
2.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
14
25
5.65
7.55
1.6
2.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
34
119
2.91
7.52
2.1
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
34
119
2.91
7.52
2.1
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
28
88
3.23
7.42
1.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
28
88
3.23
7.42
1.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
28
88
3.23
7.42
1.4
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
34
120
2.89
7.42
2.1
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
51
3.97
7.18
1.8
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
151
2.64
7.17
1.4
1.2
u/ml
2.1
3.7
0.49
19
47
(3003327) Ova and parasites identified in Stool by Light microscopy
68
337
2.08
7.15
1.5
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
288
2125
1.47
7.04
2.2
1.9
mg/l
2.7
1.1
1.40
236
1611
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
65
320
2.09
6.96
1.4
1.6
g/l
0.3
0.2
1.54
65
303
(3023199) Leukocytes [#/volume] in Pleural fluid
28
92
3.09
6.92
1.7
1.4
e6/l
1118.7
1883.0
0.72
22
62
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
11
8
13.86
6.89
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
103
2.96
6.88
1.4
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
61
302
2.08
6.45
2.2
1.5
iu/ml
1.1
0.1
0.54
11
53
(3008152) Bicarbonate [Moles/volume] in Arterial blood
98
570
1.78
6.43
12.1
7.8
mmol/l
23.0
24.5
4.20
92
536
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
19
51
3.77
6.38
1.8
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1097
10366
1.77
6.38
25.4
10.1
u/l
23.5
27.3
3.60
1091
10024
(3003434) Protein [Mass/volume] in Pleural fluid
29
104
2.83
6.18
1.7
1.4
g/l
24.6
32.1
2.85
24
92
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
63
3.38
6.01
1.8
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
84
3.02
5.98
1.7
1.4
e6/l
53260.8
22766.9
0.34
18
47
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
119
2.65
5.84
1.4
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
55
3.49
5.74
4.7
3.4
—
—
—
0
0
(3019977) pH of Arterial blood
17
47
3.66
5.49
2.2
3.9
ph
7.4
7.4
—
6
14
(3045788) Cell count panel - Pleural fluid
22
73
3.05
5.39
2.0
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
252
1900
1.41
5.34
1.6
1.7
pmol/l
22979159.0
22354840.9
0.01
235
1597
(3043409) Potassium [Moles/volume] in Arterial blood
55
283
1.99
5.29
8.5
4.0
mmol/l
4.1
3.9
2.19
50
263
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
28
109
2.61
5.16
1.5
2.2
pg
32.4
33.2
0.46
28
109
(3013512) EKG study
333
2647
1.36
5.10
5.6
3.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
26
100
2.64
4.91
2.2
2.3
e9/l
1.1
1.2
0.30
17
59
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
38
175
2.21
4.88
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
113
2.51
4.82
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
96
604
1.64
4.78
4.7
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
152
1065
1.49
4.73
1.3
1.3
—
—
—
0
0
(4281824)
24
91
2.67
4.67
1.6
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
56
305
1.88
4.60
1.6
1.3
miu/ml
169.0
237.4
0.51
17
139
(40768797) Stomach Pathology biopsy report
178
1295
1.44
4.56
1.3
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
23
87
2.68
4.50
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
149
2.25
4.46
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
74
444
1.71
4.42
8.7
3.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
55
304
1.85
4.33
1.3
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
59
995
0.57
4.31
1.2
1.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
9
8.94
4.28
1.0
1.9
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
7
6
11.73
4.28
1.4
1.3
umol/24h
272.1
356.0
—
7
6
(3034274) Bile acid [Moles/volume] in Serum --fasting
28
120
2.37
4.27
7.6
2.9
umol/l
12.5
9.3
0.39
28
87
(40768441) Liver Pathology biopsy report
21
78
2.72
4.26
2.6
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
215
1641
1.38
4.18
3.4
3.1
mmol/l
2.5
2.4
0.29
184
1460
(4306422)
32
147
2.21
4.17
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
69
413
1.71
4.17
2.0
2.1
u/l
36.5
40.0
0.68
61
370
(42529406) Shigella sp [Presence] in Stool by Culture
55
308
1.82
4.16
1.3
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
85
2.62
4.15
1.2
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
85
2.62
4.15
1.4
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
54
302
1.83
4.11
1.4
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
8
10
8.04
4.06
23.4
3.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
21
81
2.62
3.98
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
64
2.84
3.97
1.1
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
55
922
0.58
3.94
1.6
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
59
2.91
3.91
2.5
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
59
2.91
3.91
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
59
2.91
3.91
1.1
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
65
2.80
3.86
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
173
1293
1.40
3.81
1.4
1.3
titre
572.5
480.8
0.17
32
265
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
25
110
2.30
3.63
1.2
1.1
%
93.9
93.9
0.00
25
103
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
12
35
3.45
3.62
1.8
2.1
ug/l
173.5
73.2
0.61
12
35
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
23
98
2.37
3.59
1.5
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
15
51
2.97
3.58
1.0
1.6
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
7
9
7.82
3.56
1.7
1.9
ug/g
129.4
147.7
—
7
9
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.07
3.53
1.4
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.07
3.53
1.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.07
3.53
1.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
14
46
3.07
3.53
1.4
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
70
442
1.62
3.50
2.5
2.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
31
3.57
3.48
1.8
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
36
3.36
3.48
1.4
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
36
3.36
3.48
1.4
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
34
626
0.53
3.40
1.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
37
3.27
3.34
1.4
1.8
—
—
—
0
0
(4268621)
24
108
2.25
3.33
2.7
2.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
20
83
2.43
3.31
2.2
2.2
e6/l
586.3
772.6
—
9
28
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
7
8.61
3.26
1.3
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
34
177
1.95
3.26
1.5
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
78
2.46
3.22
1.8
2.4
%
15.5
12.7
—
8
46
(3007566) Smooth muscle Ab [Titer] in Serum
48
281
1.74
3.20
1.3
1.3
titre
64.0
76.5
—
5
26
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
28
3.59
3.20
1.3
1.2
%
86.1
84.4
—
10
28
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
28
3.59
3.20
1.3
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
11
6.39
3.18
1.0
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
31
158
1.99
3.16
2.7
3.0
u/ml
6.7
107.7
0.68
31
150
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
158
1.99
3.16
1.2
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
16
61
2.65
3.14
1.8
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
964
9123
1.30
3.13
42.5
14.5
%
36.5
40.1
37.52
783
6787
(3007164) IgA [Mass/volume] in Serum or Plasma
253
2060
1.29
3.12
1.6
1.5
g/l
2.1
2.3
1.32
165
1248
(3001186) Copper [Moles/volume] in Serum or Plasma
9
20
4.53
3.11
1.4
1.1
umol/l
17.7
16.5
—
9
20
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
139
2.04
3.07
1.5
1.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
29
3.47
3.05
2.4
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
29
3.47
3.05
2.4
2.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
93
2.28
3.04
1.4
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
379
3248
1.25
3.04
4.2
4.7
ug/l
2.0
2.6
1.31
352
2913
(3045142) Bone marrow Pathology biopsy report
22
100
2.22
3.00
1.4
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
26
127
2.07
2.98
2.2
2.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
28
141
2.01
2.97
1.0
1.1
g/l
1.6
1.5
0.77
28
128
(3043410) Blood group antigens tested for on Red Blood Cells
11
35
3.16
2.93
1.4
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
100
712
1.44
2.92
2.8
3.0
ng/l
497.0
169.1
4.36
95
646
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
76
2.39
2.90
1.9
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
37
207
1.81
2.89
4.7
2.2
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
6
8.36
2.75
1.4
1.3
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
6
8.36
2.75
4.4
2.2
mmol/l
4.5
4.2
—
5
6
(4062490)
21
98
2.16
2.72
1.2
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
73
2.35
2.66
3.5
1.5
g/l
0.9
1.0
0.74
17
73
(3044927) Protein electrophoresis panel - Urine
21
100
2.12
2.59
1.1
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
149
1.90
2.57
1.6
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
114
2.04
2.57
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
75
2.29
2.51
3.7
1.9
u/field
1.5
2.4
0.47
11
31
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
17
75
2.29
2.51
2.2
2.4
e9/l
0.2
0.2
1.08
17
63
(3027135) IgG subclass 1 [Mass/volume] in Serum
20
95
2.12
2.49
1.3
1.3
g/l
6.4
7.3
0.53
15
67
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
95
2.12
2.49
1.3
1.3
g/l
3.2
2.6
0.57
15
66
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
95
2.12
2.49
1.3
1.3
g/l
0.5
0.4
0.37
15
65
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
26
3.48
2.48
2.0
2.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
42
256
1.66
2.48
2.0
2.2
mg/l
16.9
11.8
1.60
36
234
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
45
2.68
2.45
2.6
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
57
2.47
2.45
1.4
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
57
2.47
2.45
1.4
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
157
1239
1.31
2.45
2.1
2.4
ug/g
161.9
120.8
0.71
131
986
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
43
265
1.65
2.44
1.5
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
46
289
1.62
2.42
1.3
1.3
—
1207.1
—
0
7
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
145
1135
1.32
2.40
17.6
6.9
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
9
27
3.35
2.39
1.1
1.3
mu/l
66.8
81.0
—
9
21
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
22
3.65
2.36
1.5
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
38
229
1.68
2.35
1.8
1.6
e6/l
43315.4
14083.8
0.37
26
174
(3039443) Prostate specific Ag panel - Serum or Plasma
9
216
0.41
2.32
1.3
1.6
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
17
78
2.20
2.31
2.2
2.4
e6/l
473.6
589.4
0.30
17
64
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
170
1.78
2.30
1.2
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
29
3.12
2.22
2.6
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
29
3.12
2.22
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
35
210
1.69
2.22
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
74
530
1.42
2.15
1.4
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
19
3.70
2.15
1.3
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
30
3.01
2.15
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
117
907
1.32
2.10
2.4
4.4
ug/l
3.3
28.5
1.95
88
752
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
62
2.27
2.08
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
10
5.02
2.07
1.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
38
2.65
2.01
2.7
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
46
305
1.53
1.98
1.4
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
21
372
0.56
1.95
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
16
3.76
1.93
1.0
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
11
45
2.46
1.93
1.8
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
34
2.66
1.86
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
33
512
0.63
1.84
1.8
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
40
2.51
1.84
1.2
1.4
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
12
4.18
1.82
1.4
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
12
53
2.28
1.81
1.0
1.5
ug/l
7.0
8.3
0.24
12
43
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
74
2.04
1.75
1.1
1.5
mmol/l
9.7
12.8
—
9
18
(3022689) Creatine [Moles/volume] in Urine
6
18
3.34
1.75
2.5
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
18
3.34
1.75
2.0
3.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
54
2.23
1.74
2.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
69
2.04
1.65
1.0
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
26
158
1.66
1.63
1.3
1.8
g/l
0.6
0.8
0.68
21
120
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
70
2.01
1.59
1.0
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
41
280
1.48
1.58
7.6
7.8
mmol/l
0.9
1.3
4.95
33
246
(1761482) Bacteria [#/volume] in Urine by Culture
35
231
1.53
1.58
7.9
4.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
114
1.77
1.57
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
12
232
0.51
1.53
1.1
1.1
u/ml
0.3
2.7
—
5
117
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
37
2.44
1.48
1.4
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
28
179
1.58
1.46
1.3
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
28
2.51
1.45
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
102
1.78
1.45
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
138
1149
1.23
1.44
6.3
4.4
%
31.6
31.8
0.12
123
784
(3002619) Bacteria identified in Specimen by Culture
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
110
1.74
1.43
1.1
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
319
3539
0.87
1.43
4.1
2.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
103
1.76
1.41
1.1
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
134
1597
0.82
1.40
1.3
1.3
iu/ml
36.8
33.2
0.07
40
505
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
45
322
1.41
1.40
2.2
2.4
u/l
7917.7
3096.4
0.68
20
129
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
60
2.01
1.38
1.4
1.6
—
—
—
0
0
(4034850)
41
291
1.42
1.34
13.4
9.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
47
2.14
1.34
2.1
3.1
u/ml
1636.9
763.2
—
10
47
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
128
1525
0.82
1.34
1.3
1.2
u/ml
5.2
12.5
1.06
44
592
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
43
2.10
1.30
2.8
1.7
iu/ml
—
2024630.0
—
0
5
(3034426) Prothrombin time (PT)
8
34
2.36
1.29
1.3
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1114
10949
1.28
1.28
62.8
19.7
e9/l
234.3
250.5
13.83
1105
10662
(3033705) Calcium.ionized [Moles/volume] in Venous blood
18
107
1.69
1.26
4.6
2.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
85
1.77
1.23
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
49
2.05
1.22
1.6
1.3
nmol/l
174.8
146.7
—
10
49
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
19
2.64
1.21
2.0
4.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1114
10957
1.27
1.20
62.8
19.7
e12/l
4.2
4.5
58.51
1105
10640
(40768795) Lymph node Pathology biopsy report
15
86
1.75
1.19
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
168
0.53
1.19
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
170
0.53
1.19
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
212
0.56
1.19
1.0
1.1
u/ml
5.0
7.1
—
6
127
(3010813) Leukocytes [#/volume] in Blood
1114
10960
1.27
1.17
62.8
19.8
e9/l
6.7
6.7
0.37
1106
10641
(3017732) Neutrophils [#/volume] in Blood
81
654
1.26
1.15
1.9
3.0
e9/l
4.3
4.0
0.64
58
516
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
20
2.51
1.15
1.2
1.0
mg/g
14.2
7.1
—
5
20
(3023419) Bacteria identified in Sputum by Culture
20
126
1.60
1.15
2.3
2.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
28
191
1.48
1.14
1.5
2.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
103
1.66
1.13
1.1
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
7
30
2.34
1.12
1.1
1.1
pmol/l
288.1
354.1
—
7
18
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
30
2.34
1.12
1.3
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
207
0.58
1.10
1.0
1.1
u/ml
11.1
1.1
—
5
110
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
168
1.50
1.10
3.0
3.1
nmol/l
0.7
0.9
0.63
17
134
(3038177) Helicobacter pylori Ab [Presence] in Serum
23
152
1.52
1.09
1.2
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
18
112
1.62
1.09
1.7
1.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
32
2.19
1.08
14.0
10.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
32
2.19
1.08
3.4
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
45
340
1.34
1.06
1.6
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
60
1.84
1.03
1.3
1.7
—
—
—
0
0
(1002224) Polysomnography panel
31
426
0.72
1.02
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
23
2.18
0.98
8.2
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
66
533
1.25
0.97
1.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
31
0.00
0.96
0.0
4.0
—
38.7
—
0
9
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
158
1388
1.16
0.96
1.5
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
55
1.83
0.92
2.0
3.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
55
1.83
0.92
1.2
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
183
0.60
0.91
2.8
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
54
672
0.79
0.90
1.4
1.2
iu/ml
137.5
127.8
0.06
17
272
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
8
43
1.87
0.87
1.0
1.1
%
137.0
112.7
—
8
37
(40768443) Skin Pathology biopsy report
50
399
1.26
0.83
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
108
933
1.17
0.83
1.3
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
30
223
1.35
0.82
1.4
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
49
606
0.80
0.79
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
48
1.67
0.79
1.9
3.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
82
1.59
0.78
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
27
0.00
0.77
0.0
1.0
—
27.5
—
0
27
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
24
2.09
0.74
1.2
1.3
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
54
1.67
0.74
1.1
1.4
—
67.8
—
0
9
(3004451) EKG impression Narrative
9
55
1.64
0.73
1.6
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
247
2277
1.11
0.72
1.3
1.3
u/ml
0.7
1.8
2.96
53
582
(3036071) Salmonella sp Ab [Titer] in Serum
7
39
1.80
0.72
1.1
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
45
363
1.25
0.71
1.2
1.2
u/ml
0.2
1.2
—
6
26
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
40
1.75
0.71
1.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
26
1.93
0.70
1.2
2.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
27
1.86
0.68
1.6
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
101
0.59
0.62
1.2
1.3
ug/l
7.8
2.9
—
6
89
(44813793)
11
71
1.55
0.62
1.1
1.1
—
—
—
0
0
(4198724)
8
49
1.64
0.62
1.1
1.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
63
1.59
0.62
1.3
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
8
50
1.60
0.61
1.9
1.7
—
11.1
—
0
6
(4133840)
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
17
227
0.75
0.53
1.1
1.6
mmol/l
3.6
3.7
0.11
17
214
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
62
1.46
0.53
1.1
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
758
7392
1.07
0.53
4.1
3.8
pmol/l
14.7
14.7
0.19
727
6725
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
97
0.62
0.52
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
40
1.50
0.51
3.3
3.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
101
1.39
0.49
1.2
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
901
8849
1.08
0.49
4.7
4.5
mu/l
2.0
2.0
0.12
868
8111
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
84
1.43
0.49
1.2
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
12
84
1.43
0.49
1.2
1.0
mg/l
302.2
274.7
0.49
12
75
(4211845)
7
45
1.56
0.49
5.6
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
277
2618
1.08
0.48
3.8
4.1
%
29.1
21.1
8.14
141
1193
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
33
398
0.82
0.48
1.6
1.5
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
7
48
1.46
0.47
1.3
1.1
—
17.1
—
0
7
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
82
0.61
0.46
1.0
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
73
820
0.88
0.45
2.5
2.2
nmol/l
12.0
13.2
0.78
65
727
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
10
69
1.45
0.44
1.1
1.2
u/ml
0.0
0.8
—
5
33
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
939
9249
1.07
0.44
7.2
4.4
mmol/l
5.9
5.9
0.77
906
8449
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
248
1.22
0.43
1.2
1.2
u/ml
6.5
10.5
—
6
34
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
1.3
—
0
7
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
11.7
—
0.5
—
0
16
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
3.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
17
0.00
0.40
0.0
5.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
34
1.47
0.40
2.2
4.5
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
0.4
—
0
11
(3000764) Benzodiazepines [Presence] in Urine
49
428
1.15
0.39
1.4
2.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
35
1.43
0.39
1.2
2.7
u/l
195.0
194.4
—
5
35
(4010399)
61
684
0.89
0.38
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
49
430
1.15
0.37
1.4
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
46
402
1.15
0.37
1.3
2.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
8
116
0.69
0.37
1.5
1.4
mmol/l
7.2
7.1
—
8
80
(3009214) Lutropin [Units/volume] in Serum or Plasma
35
300
1.17
0.36
1.5
1.5
u/l
9.4
8.9
0.06
27
242
(3028300) Cannabinoids [Presence] in Urine
49
432
1.14
0.36
1.4
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
76
0.66
0.35
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
254
1.19
0.35
1.4
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
6
42
1.43
0.35
1.7
1.4
mmol/l
5.5
6.2
—
6
42
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
43
1.40
0.35
1.2
2.2
ug/l
33.5
217.8
—
6
35
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
21
254
0.82
0.34
1.2
1.6
mg/l
586.2
510.2
0.29
21
240
(3000012) Reticulocyte production index
6
45
1.33
0.33
1.3
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
39
340
1.15
0.33
1.4
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
241
0.83
0.32
2.6
1.8
iu/l
2.9
5.0
—
6
83
(3027944) Amphetamines [Presence] in Urine
48
429
1.12
0.30
1.4
1.9
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
107
0.75
0.29
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
111
0.72
0.28
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
109
1164
0.93
0.28
1.9
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
22
186
1.19
0.28
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
41
367
1.12
0.26
1.9
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
149
0.80
0.26
1.5
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
72
1.25
0.25
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
72
1.25
0.25
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
72
1.25
0.25
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
73
1.23
0.25
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
73
1.23
0.25
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
73
1.23
0.25
1.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
107
1.22
0.21
1.4
2.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
37.6
—
0
10
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
4.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
48
1.25
0.20
1.5
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
50
1.20
0.19
1.5
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
51
1.18
0.19
2.0
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
86
814
1.06
0.18
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
23
204
1.13
0.18
1.5
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
60
1.17
0.17
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
91
1.21
0.17
2.6
3.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
152
0.85
0.17
1.2
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
18
204
0.88
0.16
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
273
1.10
0.16
1.3
1.4
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
71
1.13
0.16
1.6
1.5
—
75.4
—
0
5
(4024509)
8
71
1.13
0.16
1.9
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
28
255
1.10
0.15
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
13
112
1.16
0.14
1.3
2.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
285
0.91
0.14
1.9
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
22
199
1.11
0.13
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
621
0.95
0.12
1.9
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
15
169
0.89
0.12
1.5
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
38
356
1.07
0.12
1.8
1.5
mu/l
260.9
286.0
0.44
33
327
(3002523) Influenza virus A Ag [Presence] in Specimen
22
201
1.10
0.11
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
105
1.14
0.11
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
45
1.11
0.10
1.4
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
47
1.06
0.09
1.2
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
47
1.06
0.09
1.0
1.1
iu/ml
155.0
223.2
—
5
47
(3023323) Follitropin [Units/volume] in Serum or Plasma
39
411
0.95
0.09
1.5
1.4
iu/l
22.4
25.8
0.23
28
347
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
21
227
0.92
0.09
1.7
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
48
502
0.95
0.09
1.7
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
56
1.07
0.08
3.2
2.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
190
1933
0.98
0.08
1.5
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
67
1.05
0.08
2.7
2.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
19
176
1.08
0.07
1.7
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
8
77
1.04
0.07
1.3
1.8
mmol/l
6.2
6.7
—
8
52
(4094501)
23
245
0.94
0.07
1.1
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
126
1286
0.98
0.07
2.1
1.8
%
1.7
1.5
1.61
114
1132
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
102
1044
0.97
0.07
1.8
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
118
1.10
0.07
1.2
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
18
167
1.08
0.07
1.2
1.1
iu/ml
74.2
96.5
—
5
41
(3047352) Trisomy 18 risk [Likelihood] in Fetus
19
177
1.07
0.06
1.7
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
18
192
0.94
0.05
3.2
3.6
mg/l
26.0
25.4
—
8
120
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
18
192
0.94
0.05
1.1
1.1
—
13.8
—
0
10
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
19
201
0.94
0.04
1.2
1.2
u/ml
28.7
44.0
—
6
13
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
121
1.08
0.03
1.3
1.6
%
76.4
59.4
—
7
80
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
290
1.04
0.03
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
181
1.05
0.03
1.7
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
189
0.95
0.03
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
107
1076
0.99
0.00
1.5
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
204
0.98
0.00
1.3
1.9
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
22
224
0.98
0.00
1.3
1.9
e6/l
1661.2
964.6
0.18
16
178
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
22
224
0.98
0.00
1.3
1.8
e6/l
7.3
51.1
0.94
15
173
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
212
0.99
0.00
1.7
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
212
0.99
0.00
1.6
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
192
1916
1.00
0.00
3.0
2.9
ug/l
1.2
0.7
1.97
145
1208
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
29
289
1.00
0.00
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
213
0.99
0.00
1.7
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
213
0.99
0.00
1.7
1.4
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.6
—
0
5
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.1
—
0
5
(3032641) Amino acids panel - Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
6.3
—
0
5
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
78
0.90
0.00
1.0
1.2
mg/l
48.1
41.0
—
7
63
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
191.3
—
0
6
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(4027681)
6
64
0.94
0.00
1.2
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
74
0.95
0.00
1.0
1.1
mg/l
409.0
252.3
—
7
64
(3026470) Cobalt [Mass/volume] in Blood
5
52
0.96
0.00
2.2
2.1
ug/l
4.4
3.6
—
5
46
(3015183) Erythrocyte sedimentation rate
5
59
0.85
0.00
1.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
30
300
1.00
0.00
1.6
2.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
7.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
57
0.88
0.00
3.4
8.4
—
63.6
—
0
21
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
11.7
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
60.6
—
0
7
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
73
0.96
0.00
1.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
12.4
7.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
7
79
0.89
0.00
1.0
1.1
nmol/l
405.7
391.1
—
7
68
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
97
0.93
0.00
1.8
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CYSTIC_KIDNEY_DISEA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CYSTIC_KIDNEY_DISEA | 1.986 [1.72, 2.29] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.105 |
During the follow-up period (1.1.1998 — 31.12.2019), 491 out of 2850 females with Q17_CYSTIC_KIDNEY_DISEA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CYSTIC_KIDNEY_DISEA | 2.041 [1.76, 2.36] | < 0.001 |
| Birth year | 0.982 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 734 out of 3060 males with Q17_CYSTIC_KIDNEY_DISEA died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CYSTIC_KIDNEY_DISEA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.203% | 0.313% |
| 5 | 1.092% | 1.766% |
| 10 | 2.836% | 4.806% |
| 15 | 5.4% | 9.406% |
| 20 | 9.38% | 15.342% |
Relationships between endpoints
↥Index endpoint: Q17_CYSTIC_KIDNEY_DISEA – Cystic kidney disease
GWS hits: 12
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data